Skip to content
Clinical Trials – home
Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Sponsor

Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Spain Calle Sant Quinti 77-79, 08041 Barcelona, Spain

About the sponsor

Research activity includes myocardial revascularization, persistent atrial fibrillation, acute ischemic stroke, and intracerebral hemorrhage, with interest in perioperative protection, rhythm control, and post-stroke hemodynamic management.

  • Myocardial revascularization surgery
  • Persistent atrial fibrillation
  • Acute ischemic stroke
  • Spontaneous lobar intracerebral hemorrhage

Additional work extends to blood pressure optimization after thrombectomy and the neurological consequences of hemorrhagic brain injury.

About Specializations

Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau runs clinical trials in conditions such as Trisomy 21, Dementia Alzheimer's type, Parkinson's disease, Ischaemic stroke, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

30 clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Epinephrine
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pravastatin Sodium
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Trisomy 21+1

Recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Izaflortaucipir (18F)
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Countries:SpainSpain
  • Participants:18–64 years · Healthy volunteers
  • Substances:Florquinitau (18F)
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Levetiracetam
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Appendicectomy+1

Recruiting
Registered drug
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amiodarone Hydrochloride
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Arthralgia

Recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Triamcinolone Acetonide
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

B-cell lymphoma+2

Recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:HSP-CAR19M
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Oxytocin
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).